Literature DB >> 16510125

Ets factors regulate the polycystic kidney disease-1 promoter.

Sanjeev Puri1, Marianna Rodova, M Rafiq Islam, Brenda S Magenheimer, Robin L Maser, James P Calvet.   

Abstract

The Ets family of transcription factors consists of a group of highly conserved sequence-specific DNA binding proteins that functionally cooperate with other transcription factors to regulate a number of diverse cellular processes including proliferation, differentiation, and apoptosis. We have analyzed a 3.3kb 5'-upstream region of the human PKD1 promoter, using transient transfection in HEK293T cells and Drosophila SL2 cells, to demonstrate that the PKD1 promoter is a target of Ets family transcription factors. Our studies showed that PKD1 promoter-luciferase reporter gene expression is downregulated by cotransfected Fli-1 and is upregulated by cotransfected Ets-1. Using deletion constructs, we demonstrated that the sequences responding to Fli-1 and Ets-1 lie within the -200 to +33bp proximal promoter. This region was found to contain two putative Ets response elements (EREs): an upstream (Ets-A) sequence 5'-CGGAA-3' (-181 to -185) and a downstream (Ets-B) sequence 5'-CGGAT-3' (-129 to -133). Site-directed mutagenesis indicated that both EREs are functional. A Fli-1 DNA binding domain mutant construct (W321R), which is incapable of binding DNA, was unable to inhibit basal promoter activity. In contrast, a Fli-1 DNA binding domain truncation mutant construct, which only contains the DNA binding domain and lacks the transactivation domain, was able to inhibit. These results suggest that the effect of Fli-1 is through direct binding to these EREs. Direct binding of Fli-1 and Ets-1 to the Ets-A and Ets-B sites was supported by electrophoretic mobility shift assays. Lastly, competition between Fli-1 and Ets-1 for the two EREs was demonstrated by showing that increasing amounts of Ets-1 could overcome Fli-1 repression of promoter activity. Taken together, these experiments define the proximal PKD1 promoter region as a potential target of Ets family transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510125     DOI: 10.1016/j.bbrc.2006.02.045

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.

Authors:  Diederik van Bodegom; Wijnand Roessingh; Andrew Pridjian; Samir S El Dahr
Journal:  Biochim Biophys Acta       Date:  2010-04-11

3.  Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter.

Authors:  M Rafiq Islam; Sanjeev Puri; Marianna Rodova; Brenda S Magenheimer; Robin L Maser; James P Calvet
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-15

4.  Inactivation of max-interacting protein 1 induces renal cilia disassembly through reduction in levels of intraflagellar transport 20 in polycystic kidney.

Authors:  Je Yeong Ko; Kyung Hyun Yoo; Seon Ah Song; Do Yeon Kim; Hyun Kyung Kong; Curie Ahn; Han Woong Lee; Duk-Hee Kang; Goo Taeg Oh; Jong Hoon Park
Journal:  J Biol Chem       Date:  2013-01-13       Impact factor: 5.157

5.  FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.

Authors:  Kamala P Sundararaj; Thirumagal Thiyagarajan; Ivan Molano; Fahmin Basher; Thomas W Powers; Richard R Drake; Tamara K Nowling
Journal:  J Immunol       Date:  2015-11-04       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.